Brief: Paion Says FDA Accepted New Drug Application For Remimazolam In The U.S.

PAION AG

10/06/2019 09:40

June 10 (Reuters) - PAION AG  PA8G.DE :
    * FDA ACCEPTS FILING OF NDA FOR REMIMAZOLAM IN THE U.S.
    * FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED
REMIMAZOLAM NEW
DRUG APPLICATION (NDA) FOR REVIEW IN INDICATION PROCEDURAL
SEDATION

Source text for Eikon:  ID:nEQ66xDV2a 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))